Guillaume Dumond Fillon

Guillaume Dumond Fillon has extensive work experience in portfolio management and project leadership roles within the healthcare industry. Guillaume is currently serving as the Director Global Portfolio Management CHC at the STADA Group since 2021. Prior to this, Guillaume worked at Procter & Gamble from 2018 to 2021, where they held the positions of Global PMO Director and Global Franchise Portfolio Director. Before that, they worked at Merck Consumer Health (Germany) from 2009 to 2018, where they held several roles including Global Franchise Portfolio Director, R&D Brand Innovator, and International Project Leader. Guillaume also briefly served as the Regional R&D Head at Merck Consumer Health. Guillaume began their career at Merck Consumer Healthcare (France) in 2006, where they were responsible for scientific research. Overall, Guillaume has a strong background in portfolio management, project/program management, and innovation strategy within the healthcare industry.

Guillaume Dumond Fillon, MBA, PMP, completed their education at various institutions. In 2000-2003, they earned a DEUG in Biology and Biochemistry from Université de Bourgogne. Guillaume then pursued a Bachelor's degree in Cellular Biology and Physiology from 2003-2004, followed by a Master's degree in Cellular Biology & Physiology from 2004-2005, both at Université de Bourgogne. In 2005-2006, Guillaume obtained a Professional Master's degree in Health & Nutrition from the same university. Later, from 2015-2017, they completed an Essec & Mannheim Executive MBA from ESSEC Business School and Mannheim Business School. Additionally, in 2016, they attended a Residency program at UCLA Anderson School of Management for a Global Management Seminar, and also participated in an Essec and Mannheim Study tour on Innovation and Business in Asia at Yonsei University. Guillaume Dumond Fillon holds a Project Management Professional (PMP) certification from the Project Management Institute, obtained in 2014.